Jackson Creek Investment Advisors LLC Gilead Sciences, Inc. Transaction History

Jackson Creek Investment Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$77.31 - $88.08 $371,551 - $423,312	4,806 Added 71.3%	11,547 $958,000
Q4 2022 Feb 03, 2023	BUY	$62.32 - $89.47 $420,099 - $603,117	6,741 New	6,741 $579,000
Q2 2021 Aug 03, 2021	SELL	$63.47 - $69.35 $201,771 - $220,463	-3,179 Closed	0 $0
Q1 2021 May 27, 2021	BUY	$60.0 - $68.46 $190,740 - $217,634	3,179 New	3,179 $205,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.